A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery

被引：0
|
作者：
R. C. G. Gallandat Huet
A. W. Siemons
D. Baus
W. T. van Rooyen-Butijn
J. A. M. Haagenaars
W. van Oeveren
F. Bepperling
机构：
[1] University Hospital Groningen,Department of Biomedical Engineering
[2] Hospital De Weezenlanden,Department of Thoracic Anesthesiology and Intensive Care
[3] Fresenius Kabi Deutschland GmbH,Fluid Therapy Division
[4] University Hospital Groningen,Department of Anesthesiology
来源：
Canadian Journal of Anesthesia | 2000年 / 47卷 / 12期
关键词：
Pulmonary Capillary Wedge Pressure; Hydroxyethyl Starch; Clin Drug Invest; Colloid Osmotic Pressure; Hetastarch;
D O I：
10.1007/BF03019870
中图分类号：
学科分类号：
摘要：
Purpose: To compare the new hydroxyethyl starch HES 130/0.4 (Voluven®) and the standard HES 200/0.5 (pentastarch) regarding effectiveness for plasma volume substitution and safety of large volumes in heart surgery.
引用
收藏
页码：1207 / 1215
页数：8
相关论文
共 50 条
  • [1] A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery
    Huet, RCGG
    Siemons, AW
    Baus, D
    van Rooyen-Butijn, WT
    Haagenaars, JAM
    van Oeveren, W
    Bepperling, F
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2000, 47 (12): : 1207 - 1215
  • [2] Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
    Philippe Van der Linden
    Melanie Dumoulin
    Celine Van Lerberghe
    Cristel Sanchez Torres
    Ariane Willems
    David Faraoni
    Critical Care, 19
  • [3] Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
    Van der Linden, Philippe
    Dumoulin, Melanie
    Van Lerberghe, Celine
    Torres, Cristel Sanchez
    Willems, Ariane
    Faraoni, David
    CRITICAL CARE, 2015, 19
  • [4] Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery
    McConnell, Matthew
    Baisden, Josh
    Duncan, Andra E.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (01) : 570 - 575
  • [5] HYDROXYETHYL STARCH - AN ALTERNATIVE TO PLASMA FOR POSTOPERATIVE VOLUME EXPANSION AFTER CARDIAC-SURGERY
    MUNSCH, CM
    MACINTYRE, E
    MACHIN, SJ
    MACKIE, IJ
    TREASURE, T
    BRITISH JOURNAL OF SURGERY, 1988, 75 (07) : 675 - 678
  • [6] Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement is safe and effective in children
    R Suempelmann
    W Osthaus
    Critical Care, 12 (Suppl 2):
  • [7] Volume replacement therapy during major orthopedic surgery using Voluven® (hydroxyethyl starch 130/0.4) or hetastarch
    Gandhi, Sweeta D.
    Weiskopf, Richard B.
    Jungheinrich, Cornelius
    Koorn, Robert
    Miller, Diane
    Shangraw, Robert E.
    Prough, Donald S.
    Baus, Daniela
    Bepperling, Frank
    Warltier, David C.
    ANESTHESIOLOGY, 2007, 106 (06) : 1120 - 1127
  • [8] Changes in circulating blood volume after cardiac surgery measured by a novel method using hydroxyethyl starch
    Tschaikowsky, K
    Neddermeyer, U
    Pscheidl, E
    von der Emde, J
    CRITICAL CARE MEDICINE, 2000, 28 (02) : 336 - 341
  • [9] Is hydroxyethyl starch 130/0.4 the optimal starch plasma substitute in adult cardiac surgery?
    Huet, R
    Siemons, W
    Hagenaars, A
    Von Oeveren, W
    ANESTHESIA AND ANALGESIA, 1998, 86 (04): : SCA80 - SCA80
  • [10] EVALUATION OF THE RISK OF ACUTE KIDNEY INJURY ASSOCIATED WITH THE USE OF HYDROXYETHYL STARCH 130/0.4 (VOLUVEN 6%) IN CARDIAC SURGERY
    Frenette, A. J.
    Bernier, P.
    Charbonneau, A.
    Nguyen, L. T.
    Troyanov, S.
    Rioux, J. P.
    Heylbroeck, C.
    Williamson, D.
    INTENSIVE CARE MEDICINE, 2011, 37 : S255 - S255
12345